Markus Laube - Concepedia

Author

Markus Laube

Helmholtz-Zentrum Dresden-Rossendorf ORCID

Also Known As

Laube, M., Laube, Markus, M Laube, M. Laube, Markus Laube

162

Publications

916

Citations

H-Index

Concepts

All Affiliations

Helmholtz-Zentrum Dresden-Rossendorf Technische Universität Dresden Leipzig University University of Belgrade National Center for Tumor Diseases

About

Markus Laube is an author at Helmholtz-Zentrum Dresden-Rossendorf specializing in medicinal chemistry, natural sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	5	5	134
2	Medicine	4	4	99
3	Biochemistry	4	4	107
4	Engineering	2	2	55
5	Health Sciences	1	1	41

Markus Laube

Publications

535

Citations

H-Index

Page 1

	Year	Citations
Radiosynthesis of a 18F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivo Markus Laube, Ralf Bergmann, Fabian Sehn, Bioorganic & Medicinal Chemistry BiosynthesisBiochemistryNatural Sciences18F-labeled 2,3-Diarylsubstituted IndoleMolecular Biology	2012	50
2-[<sup>18</sup>F]Fluoroethyl tosylate – a versatile tool for building<sup>18</sup>F-based radiotracers for positron emission tomography Markus Laube, Peter Brust, Jörg Steinbach MedChemComm EngineeringAdvanced ImagingOrganic ChemistryChemistryPet Radiotracer Design	2015	41
Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies Diana Isabel Sandoval Bojórquez, Željko Janićijević, Brenda Palestina Romero, ACS Sensors	2023	34
“Clickable” Albumin Binders for Modulating the Tumor Uptake of Targeted Radiopharmaceuticals Florian Brandt, Martin Ullrich, Markus Laube, Journal of Medicinal Chemistry	2021	32
Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines Antonio Buzharevski, Svetlana Paskaš, Menyhárt B. Sárosi, ChemMedChem Medicinal ChemistryNonsteroidal Anti-inflammatory DrugsHuman MelanomaMedicineCarboranyl Analogues	2019	29
2‐Carbaborane‐3‐phenyl‐1<i>H</i>‐indoles—Synthesis via McMurry Reaction and Cyclooxygenase (COX) Inhibition Activity Markus Laube, Wilma Neumann, M. Scholz, ChemMedChem	2013	27
2,3-Diaryl-substituted indole based COX-2 inhibitors as leads for imaging tracer development Markus Laube, Christoph Tondera, Sai Kiran Sharma, RSC Advances Chemoprevention StrategyTracer DevelopmentOrganic ChemistryPharmacotherapyChemistry	2014	27
Development of an <sup>18</sup>F-Labeled Irreversible Inhibitor of Transglutaminase 2 as Radiometric Tool for Quantitative Expression Profiling in Cells and Tissues Robert Wodtke, Johanna Wodtke, Sandra Hauser, Journal of Medicinal Chemistry	2021	26
Diaryl-Substituted (Dihydro)pyrrolo[3,2,1-<i>hi</i>]indoles, a Class of Potent COX-2 Inhibitors with Tricyclic Core Structure Markus Laube, Cemena Gassner, Sai Kiran Sharma, The Journal of Organic Chemistry Positron Emission TomographyNew Compound ClassMedicinal ChemistryCombinatorial ChemistryBiochemistry	2015	25
Carboranyl Analogues of Mefenamic Acid and Their Biological Evaluation Liridona Useini, Marija Mojić, Markus Laube, ACS Omega	2022	25

Page 1